Chronic Myeloid Leukemia Relapsing 25 Years after Allogenic Stem Cell Transplantation
Chronic myeloid leukemia (CML) is a myeloproliferative disorder in which neoplastic cells exhibit the Philadelphia chromosome and the related oncoprotein BCR-ABL1. Allogeneic stem cell transplantation (allo-SCT) was considered the first-line treatment for CML, before the introduction of tyrosine kin...
Saved in:
Main Authors: | Håkon Reikvam, Jørn Skavland, Stein-Erik Gullaksen, Randi Hovland, Tobias Gedde-Dahl, Øystein Bruserud, Bjørn Tore Gjertsen |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-01-01
|
Series: | Case Reports in Hematology |
Online Access: | http://dx.doi.org/10.1155/2018/2045985 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Preconditioning Serum Levels of Endothelial Cell-Derived Molecules and the Risk of Posttransplant Complications in Patients Treated with Allogeneic Stem Cell Transplantation
by: Roald Lindås, et al.
Published: (2014-01-01) -
Pure Red Cell Aplasia with Del(20q) Sensitive for Immunosuppressive Treatment
by: Anh Khoi Vo, et al.
Published: (2020-01-01) -
Sacral Myeloid Sarcoma Manifesting as Radiculopathy in a Pediatric Patient: An Unusual Form of Myeloid Leukemia Relapse
by: Joana Ruivo Rodrigues, et al.
Published: (2018-01-01) -
Limbic Encephalitis following Allogeneic Hematopoietic Stem Cell Transplantation
by: Silje Johansen, et al.
Published: (2022-01-01) -
Intermediate-High Risk Pulmonary Embolism: The Use of Riociguat and Inferior Vena Cava Filter in a Situation of Recurrent Embolism following Insufficient Anticoagulation and Fibrinolytic Therapy
by: Anh Khoi Vo, et al.
Published: (2020-01-01)